OBJECTIVE: HIV infection and illicit drug use are each associated with diminished cognitive performance. This study examined the separate and interactive effects of HIV and recent illicit drug use on verbal memory, processing speed, and executive function in the multicenter Women's Interagency HIV Study. METHODS: Participants included 952 HIV-infected and 443 HIV-uninfected women (mean age = 42.8, 64% African-American). Outcome measures included the Hopkins Verbal Learning Test-Revised and the Stroop test. Three drug use groups were compared: recent illicit drug users (cocaine or heroin use in past 6 months, n = 140), former users (lifetime cocaine or heroin use but not in past 6 months, n = 651), and nonusers (no lifetime use of cocaine or heroin, n = 604). RESULTS: The typical pattern of recent drug use was daily or weekly smoking of crack cocaine. HIV infection and recent illicit drug use were each associated with worse verbal learning and memory (P < 0.05). Importantly, there was an interaction between HIV serostatus and recent illicit drug use such that recent illicit drug use (compared with nonuse) negatively impacted verbal learning and memory only in HIV-infected women (P < 0.01). There was no interaction between HIV serostatus and illicit drug use on processing speed or executive function on the Stroop test. CONCLUSIONS: The interaction between HIV serostatus and recent illicit drug use on verbal learning and memory suggests a potential synergistic neurotoxicity that may affect the neural circuitry underlying performance on these tasks.
OBJECTIVE:HIV infection and illicit drug use are each associated with diminished cognitive performance. This study examined the separate and interactive effects of HIV and recent illicit drug use on verbal memory, processing speed, and executive function in the multicenter Women's Interagency HIV Study. METHODS:Participants included 952 HIV-infected and 443 HIV-uninfectedwomen (mean age = 42.8, 64% African-American). Outcome measures included the Hopkins Verbal Learning Test-Revised and the Stroop test. Three drug use groups were compared: recent illicit drug users (cocaine or heroin use in past 6 months, n = 140), former users (lifetime cocaine or heroin use but not in past 6 months, n = 651), and nonusers (no lifetime use of cocaine or heroin, n = 604). RESULTS: The typical pattern of recent drug use was daily or weekly smoking of crack cocaine. HIV infection and recent illicit drug use were each associated with worse verbal learning and memory (P < 0.05). Importantly, there was an interaction between HIV serostatus and recent illicit drug use such that recent illicit drug use (compared with nonuse) negatively impacted verbal learning and memory only in HIV-infectedwomen (P < 0.01). There was no interaction between HIV serostatus and illicit drug use on processing speed or executive function on the Stroop test. CONCLUSIONS: The interaction between HIV serostatus and recent illicit drug use on verbal learning and memory suggests a potential synergistic neurotoxicity that may affect the neural circuitry underlying performance on these tasks.
Authors: Jennifer J Manly; Diane M Jacobs; Pegah Touradji; Scott A Small; Yaakov Stern Journal: J Int Neuropsychol Soc Date: 2002-03 Impact factor: 2.892
Authors: Jordan E Cattie; Steven Paul Woods; Miguel Arce; Erica Weber; Dean C Delis; Igor Grant Journal: Clin Neuropsychol Date: 2012-03-07 Impact factor: 3.535
Authors: Eileen M Martin; David L Pitrak; William Weddington; Niles A Rains; Gerald Nunnally; Heather Nixon; Silvana Grbesic; Jasmin Vassileva; Antoine Bechara Journal: J Int Neuropsychol Soc Date: 2004-11 Impact factor: 2.892
Authors: G Peavy; D Jacobs; D P Salmon; N Butters; D C Delis; M Taylor; P Massman; J C Stout; W C Heindel; D Kirson Journal: J Clin Exp Neuropsychol Date: 1994-08 Impact factor: 2.475
Authors: Vanessa J Meyer; Deborah M Little; Daniel A Fitzgerald; Erin E Sundermann; Leah H Rubin; Eileen M Martin; Kathleen M Weber; Mardge H Cohen; Pauline M Maki Journal: J Neurovirol Date: 2014-04-24 Impact factor: 2.643
Authors: David E Vance; Leah H Rubin; Victor Valcour; Drenna Waldrop-Valverde; Pauline M Maki Journal: Curr HIV/AIDS Rep Date: 2016-12 Impact factor: 5.071
Authors: G Cristina Brailoiu; Elena Deliu; Jeffrey L Barr; Linda M Console-Bram; Alexandra M Ciuciu; Mary E Abood; Ellen M Unterwald; Eugen Brailoiu Journal: Drug Alcohol Depend Date: 2017-06-08 Impact factor: 4.492
Authors: Seth M Dever; Blair N Costin; Ruqiang Xu; Nazira El-Hage; Joyce Balinang; Alexander Samoshkin; Megan A O'Brien; Marypeace McRae; Luda Diatchenko; Pamela E Knapp; Kurt F Hauser Journal: AIDS Date: 2014-01-02 Impact factor: 4.177
Authors: Eileen Martin; M K Keutmann; J S Fogel; P M Maki; R Gonzalez; J Vassileva; L H Rubin; D Hardy Journal: J Neurovirol Date: 2018-04-23 Impact factor: 2.643
Authors: Emily C Williams; Judith A Hahn; Richard Saitz; Kendall Bryant; Marlene C Lira; Jeffrey H Samet Journal: Alcohol Clin Exp Res Date: 2016-09-22 Impact factor: 3.455